UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice

PloS one, 2014-03, Vol.9 (3), p.e91514-e91514

2014

Volltextzugriff (PDF)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity

Molecular metabolism (Germany), 2021-03, Vol.45, p.101157-101157, Article 101157

2021

Volltextzugriff (PDF)

FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1)

PloS one, 2015-02, Vol.10 (2), p.e0117665-e0117665

2015

Volltextzugriff (PDF)

Defective lysosome reformation during autophagy causes skeletal muscle disease

The Journal of clinical investigation, 2021-01, Vol.131 (1), p.1-16

2021

Volltextzugriff (PDF)

Modulation of Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein Interactions Enhances Skeletal Muscle Regeneration and Ameliorates the Dystrophic Pathology in mdx Mice

The American journal of pathology, 2007-10, Vol.171 (4), p.1180-1188

2007

Volltextzugriff (PDF)

Hsp72 preserves muscle function and slows progression of severe muscular dystrophy

Nature (London), 2012-04, Vol.484 (7394), p.394-398

2012

Volltextzugriff (PDF)

Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage

Experimental physiology, 2008-11, Vol.93 (11), p.1190-1198

2008

Volltextzugriff (PDF)

Intramuscular β2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury

Journal of applied physiology (1985), 2008-07, Vol.105 (1), p.165-172

2008

Volltextzugriff (PDF)

BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle

The American journal of pathology, 2016-12, Vol.186 (12), p.3246-3260

2016

Volltextzugriff (PDF)

Making Fast-Twitch Dystrophic Muscles Bigger Protects Them from Contraction Injury and Attenuates the Dystrophic Pathology

The American journal of pathology, 2010, Vol.176 (1), p.29-33

2010

Volltextzugriff (PDF)

Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β‐adrenoceptor stimulation in mice

The Journal of physiology, 2010-12, Vol.588 (23), p.4811-4823

2010

Volltextzugriff (PDF)

Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice

Diabetes, obesity & metabolism, 2017-07, Vol.19 (7), p.936-943

2017

Volltextzugriff (PDF)

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy

Experimental physiology, 2014-04, Vol.99 (4), p.675-687

2014

Volltextzugriff (PDF)

Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy

Human molecular genetics, 2014-02, Vol.23 (3), p.618-636

2014

Volltextzugriff (PDF)

Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice

Fibrogenesis & tissue repair, 2014-01, Vol.7 (1), p.1-1, Article 1

2014

Volltextzugriff (PDF)

Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence

American journal of physiology. Regulatory, integrative and comparative physiology, 2011-11, Vol.301 (5), p.R1358-R1366

2011

Volltextzugriff (PDF)

Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy

Growth hormone & IGF research, 2012-04, Vol.22 (2), p.69-75

2012

Volltextzugriff (PDF)

Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury

Growth hormone & IGF research, 2013-08, Vol.23 (4), p.128-133

2013

Volltextzugriff (PDF)

Emerging drugs for treating skeletal muscle injury and promoting muscle repair

Expert opinion on emerging drugs, 2011-03, Vol.16 (1), p.163-182

2011

Volltextzugriff (PDF)

Chronic formoterol administration reduces cardiac mitochondrial protein synthesis and oxidative capacity in mice

International journal of cardiology, 2011-01, Vol.146 (2), p.270-272

2011

Volltextzugriff (PDF)

Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice

The Journal of physiology, 2010-12, Vol.588 (Pt 23), p.4811

2010

Volltextzugriff (PDF)

Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β-adrenoceptor stimulation in mice: Acute vs. chronic anabolic response to β-agonists

The Journal of physiology, 2010-12, Vol.588 (23), p.4811-4823

2010

Volltextzugriff (PDF)

Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence

American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Vol.70 (5)

2011

Volltextzugriff (PDF)

Intramuscular β 2 -agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury

Journal of applied physiology (1985), 2008-07, Vol.105 (1), p.165-172

2008

Volltextzugriff (PDF)

Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury

Journal of applied physiology (1985), 2008-07, Vol.105 (1), p.165

2008

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity

FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1)

Defective lysosome reformation during autophagy causes skeletal muscle disease

Modulation of Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein Interactions Enhances Skeletal Muscle Regeneration and Ameliorates the Dystrophic Pathology in mdx Mice

Hsp72 preserves muscle function and slows progression of severe muscular dystrophy

Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage

Intramuscular β2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury

BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle

Making Fast-Twitch Dystrophic Muscles Bigger Protects Them from Contraction Injury and Attenuates the Dystrophic Pathology

Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β‐adrenoceptor stimulation in mice

Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy

Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy

Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice

Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence

Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy

Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury

Emerging drugs for treating skeletal muscle injury and promoting muscle repair

Chronic formoterol administration reduces cardiac mitochondrial protein synthesis and oxidative capacity in mice

Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice

Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β-adrenoceptor stimulation in mice: Acute vs. chronic anabolic response to β-agonists

Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence

Intramuscular β 2 -agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury

Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury

Suchergebnisse filtern